Without mentioning numbers, it would be interesting to learn how many investors on the forum managed to outperform the main US indices during 2017. While many would struggle to maintain the performance of the main indices, those with a technology bias to their investments may well have outperformed.
I have gone very long on a small UK based pharmaceutical company by the name of Angle (AGL) which has been volatile but that is only to be expected in this sector. I have very high hopes for the future!
